These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Acute effects of insulin in the control of VLDL production in humans. Implications for the insulin-resistant state. Lewis GF; Steiner G Diabetes Care; 1996 Apr; 19(4):390-3. PubMed ID: 8729170 [TBL] [Abstract][Full Text] [Related]
23. The effect of continuous subcutaneous insulin infusion on very-low-density lipoprotein triglyceride metabolism in type I diabetes mellitus. Pietri AO; Dunn FL; Grundy SM; Raskin P Diabetes; 1983 Jan; 32(1):75-81. PubMed ID: 6848399 [No Abstract] [Full Text] [Related]
24. Effects of NIDDM on very-low-density lipoprotein triglyceride and apolipoprotein B metabolism. Studies before and after sulfonylurea therapy. Taskinen MR; Beltz WF; Harper I; Fields RM; Schonfeld G; Grundy SM; Howard BV Diabetes; 1986 Nov; 35(11):1268-77. PubMed ID: 3530855 [TBL] [Abstract][Full Text] [Related]
25. Retinol-binding protein 4 is an independent factor associated with triglycerides and a determinant of very low-density lipoprotein-apolipoprotein B100 catabolism in type 2 diabetes mellitus. Vergès B; Guiu B; Cercueil JP; Duvillard L; Robin I; Buffier P; Bouillet B; Aho S; Brindisi MC; Petit JM Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):3050-7. PubMed ID: 23087360 [TBL] [Abstract][Full Text] [Related]
26. Attenuated suppression of lipolysis explains the increases in triglyceride secretion and concentration associated with basal insulin peglispro relative to insulin glargine treatment in patients with type 1 diabetes. Johansen RF; Søndergaard E; Linnebjerg H; Garhyan P; Lam ECQ; Porksen N; Jacober SJ; Nielsen S Diabetes Obes Metab; 2018 Feb; 20(2):419-426. PubMed ID: 28817248 [TBL] [Abstract][Full Text] [Related]
27. The immediate effects of insulin and fructose on the metabolism of the perfused liver. Changes in lipoprotein secretion, fatty acid oxidation and esterification, lipogenesis and carbohydrate metabolism. Topping DL; Mayes PA Biochem J; 1972 Jan; 126(2):295-311. PubMed ID: 5071176 [TBL] [Abstract][Full Text] [Related]
28. Metabolic abnormalities of apolipoprotein B-containing lipoproteins in non-insulin-dependent diabetes: a stable isotope kinetic study. Duvillard L; Pont F; Florentin E; Galland-Jos C; Gambert P; Vergès B Eur J Clin Invest; 2000 Aug; 30(8):685-94. PubMed ID: 10964160 [TBL] [Abstract][Full Text] [Related]
29. Chronic exogenous hyperinsulinaemia does not modify the acute inhibitory effect of insulin on the secretion of very-low-density lipoprotein triacylglycerol and apolipoprotein B in primary cultures of rat hepatocytes. Bourgeois CS; Wiggins D; Gibbons GF Biochem J; 1996 Feb; 314 ( Pt 1)(Pt 1):103-8. PubMed ID: 8660269 [TBL] [Abstract][Full Text] [Related]
30. Effects of insulin on whole-body and regional amino acid metabolism. Tessari P Diabetes Metab Rev; 1994 Oct; 10(3):253-85. PubMed ID: 7835172 [No Abstract] [Full Text] [Related]
31. Cholesterol is required for secretion of very-low-density lipoprotein by rat liver. Khan B; Wilcox HG; Heimberg M Biochem J; 1989 Mar; 258(3):807-16. PubMed ID: 2730568 [TBL] [Abstract][Full Text] [Related]
32. Coordination of very low-density lipoprotein triglyceride and apolipoprotein B metabolism in humans: effects of obesity and non-insulin-dependent diabetes mellitus. Howard BV; Abbott WG; Egusa G; Taskinen MR Am Heart J; 1987 Feb; 113(2 Pt 2):522-6. PubMed ID: 3544765 [TBL] [Abstract][Full Text] [Related]
33. Hepatic metabolism of free fatty acids in experimental diabetes. Woodside WF; Heimberg M Isr J Med Sci; 1972 Mar; 8(3):309-16. PubMed ID: 4339335 [No Abstract] [Full Text] [Related]
34. The effect of a six-month exercise program on very low-density lipoprotein apolipoprotein B secretion in type 2 diabetes. Alam S; Stolinski M; Pentecost C; Boroujerdi MA; Jones RH; Sonksen PH; Umpleby AM J Clin Endocrinol Metab; 2004 Feb; 89(2):688-94. PubMed ID: 14764782 [TBL] [Abstract][Full Text] [Related]
35. GLP-1 Elicits an Intrinsic Gut-Liver Metabolic Signal to Ameliorate Diet-Induced VLDL Overproduction and Insulin Resistance. Khound R; Taher J; Baker C; Adeli K; Su Q Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2252-2259. PubMed ID: 29074588 [TBL] [Abstract][Full Text] [Related]
36. Hepatic VLDL production in ob/ob mice is not stimulated by massive de novo lipogenesis but is less sensitive to the suppressive effects of insulin. Wiegman CH; Bandsma RH; Ouwens M; van der Sluijs FH; Havinga R; Boer T; Reijngoud DJ; Romijn JA; Kuipers F Diabetes; 2003 May; 52(5):1081-9. PubMed ID: 12716736 [TBL] [Abstract][Full Text] [Related]
37. Lipogenesis and the synthesis and secretion of very low density lipoprotein by avian liver cells in nonproliferating monolayer culture. Hormonal effects. Tarlow DM; Watkins PA; Reed RE; Miller RS; Zwergel EE; Lane MD J Cell Biol; 1977 May; 73(2):332-53. PubMed ID: 192733 [TBL] [Abstract][Full Text] [Related]
39. "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Björntorp P Arteriosclerosis; 1990; 10(4):493-6. PubMed ID: 2196039 [No Abstract] [Full Text] [Related]
40. Effects of insulin and glucose on very low density lipoprotein triglyceride secretion by cultured rat hepatocytes. Durrington PN; Newton RS; Weinstein DB; Steinberg D J Clin Invest; 1982 Jul; 70(1):63-73. PubMed ID: 7045162 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]